John Deeken
President, Inova Schar Cancer | Medical Oncologist · Inova Fairfax Hospital Campus
Credentials: · · · ·
History
- Present
Inova Schar Cancer | Medical Oncologist · Inova Fairfax Hospital Campus
- 2004–2006
Research
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · 2,193 citations
The blood-brain barrier and cancer: transporters, treatment, and Trojan horses
Review · Clinical Cancer Research · 2007 · First of 2 authors · Corresponding · 550 citations
ABCG2: determining its relevance in clinical drug resistance
Review · Cancer metastasis reviews · 2007 · 314 citations
13 papers
12 papers
- MP
11 papers
- JN
8 papers
7 papers
6 papers
- TC
6 papers
- DS
5 papers
Clinical trials
- 2023–2026
Principal investigator · Recruiting
Inova Health Care Services
- 2015
Phase I Study of Intravenous Artesunate for Solid Tumors
Principal investigator · Completed · Phase 1
Georgetown University
- 2012–2013
Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
Principal investigator · Terminated
Georgetown University
- 2009–2013
Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Principal investigator · Withdrawn · Phase 2
Georgetown University